iHuman Inc. (NYSE:IH - Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 7,500 shares, an increase of 127.3% from the September 30th total of 3,300 shares. Based on an average daily trading volume, of 44,200 shares, the short-interest ratio is currently 0.2 days.

IH stock traded down $0.05 during midday trading on Friday, hitting $1.80. 14,548 shares of the stock were exchanged, compared to its average volume of 41,832. The stock's 50-day moving average price is $1.77 and its 200-day moving average price is $1.77. The stock has a market cap of $94.27 million, a price-to-earnings ratio of 5.29 and a beta of 0.43. iHuman has a fifty-two week low of $1.50 and a fifty-two week high of $3.18.

iHuman (NYSE:IH - Get Free Report) last issued its quarterly earnings data on Friday, September 27th. The company reported $0.06 earnings per share (EPS) for the quarter. The firm had revenue of $29.60 million during the quarter. iHuman had a return on equity of 14.17% and a net margin of 13.72%.

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.